premature ejaculation
Information
- Disease name
- premature ejaculation
- Disease ID
- DOID:13709
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes | Mutation | Description | Source | Links |
---|
NCT ID | Status | Phase | Summary | Start date | Completion date |
---|---|---|---|---|---|
NCT00370981 | Completed | Phase 2 | Exploratory Study of Pagoclone in Men With Premature Ejaculation. | July 2006 | October 2006 |
NCT00556478 | Completed | Phase 2/Phase 3 | Efficacy, Safety and Tolerability of PSD502 (a Topical Anesthetic) in the Treatment Premature Ejaculation | October 2007 | October 2009 |
NCT00664365 | Completed | Phase 1 | FTIH Study With GSK958108 | April 12, 2008 | August 22, 2008 |
NCT00861484 | Completed | Phase 1 | Proof of Mechanism in ELT | November 26, 2008 | December 11, 2009 |
NCT01021553 | Completed | Phase 2 | A Study To Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Two Oral Doses of GSK557296 in a Study in Men With Premature Ejaculation | December 23, 2009 | May 5, 2011 |
NCT01024491 | Completed | Phase 3 | Efficacy and Safety of Paroxetine Daily Doses of 15 mg and 20 mg in the Treatment of Premature Ejaculation | August 2008 | April 2009 |
NCT01183208 | Completed | Phase 1 | A Safety and Tolerability Study of Administration of PSD502 | December 2009 | February 2010 |
NCT01184105 | Completed | Phase 1 | A Safety and Tolerability of PSD502 (a Topical Anesthetic) in the Treatment of Premature Ejaculation | September 2010 | November 2010 |
NCT01203202 | Completed | Phase 2 | Phase 2 Trial of PED-1 and PED-2 in Male Patients With Premature Ejaculation | September 2010 | January 2011 |
NCT01419470 | Completed | Phase 1/Phase 2 | Safety, Tolerability, Pharmacokinetics and Efficacy of YHD1044 | February 2011 | May 2012 |
NCT01439984 | Completed | Phase 3 | Trial of PED-1 in Male Patients With Premature Ejaculation | September 2011 | June 2012 |
NCT02232425 | Completed | Phase 2 | IX-01 Effect on Intravaginal Ejaculatory Latency Time (IELT) and Patient Reported Outcomes in Men With Premature Ejaculation (PE) | September 2014 | October 2015 |
NCT02297152 | Completed | N/A | A New Treatment for Premature Ejaculation? | May 2014 | October 2014 |
NCT02572037 | Completed | Research and Clinical Value of New Classification for Premature Ejaculation: Multi-Center Research | October 2015 | July 30, 2017 | |
NCT02794454 | Completed | N/A | A Study to Evaluate Efficacy of Investigational Product HeezOn Ultra -1/ HeezOn Ultra-2 on Male Sexual Health | May 2016 | January 2017 |
NCT02844998 | Completed | N/A | The Impact and Benefit of Physical Activity on Premature Ejaculation | January 2015 | July 2016 |
NCT02939495 | Completed | Phase 4 | The Efficacy and Safety of Dapoxetine/Sildenafil Combination Therapy | October 2016 | August 2017 |
NCT02984592 | Completed | Effect of Exercise on Premature Ejaculation | November 2016 | January 31, 2017 | |
NCT03055806 | Completed | Phase 2 | IX-01 Effect on Intravaginal Ejaculatory Latency Time (IELT), Patient Reported Outcomes and Safety in Men With Premature Ejaculation (PE) | February 28, 2017 | December 6, 2017 |
NCT03174470 | Completed | N/A | Safety Demonstration of Increasing Intensities of Electrical Stimulation Delivered to The Bulbospongiosus Muscle | November 2, 2016 | June 30, 2017 |
NCT03204890 | Completed | N/A | TPTNS for Treating Patients With Premature Ejaculation | June 14, 2017 | October 30, 2018 |
NCT03304808 | Completed | N/A | Efficacy of a New Behavioral Treatment for Premature Ejaculation Using a Masturbation Aid Device: Star-Stop 3.0 | October 1, 2017 | December 1, 2017 |
NCT03459833 | Completed | Phase 3 | Glans Penis Augmentation by Hyaluronic Acid for Treatment of Premature Ejaculation | August 19, 2016 | March 2018 |
NCT03578783 | Completed | Phase 2 | PSD502 in Subjects With Premature Ejaculation | December 26, 2018 | December 1, 2021 |
NCT03942367 | Completed | N/A | Evaluation of the Safety and Effectiveness of the vPatch Device | September 10, 2019 | July 16, 2020 |
NCT04012437 | Completed | N/A | Efficacy of App and Electronic Device in the Treatment of Premature Ejaculation | July 1, 2019 | December 30, 2019 |
NCT04085354 | Completed | Phase 3 | Evaluation of the Clinical Efficacy and Safety of Dapoxetine, Combined Dapoxetine With Folic Acid and Combined Dapoxetine With Vitamin B12 in Treatment of Patients With Premature Ejaculation | February 10, 2019 | August 29, 2019 |
NCT04841395 | Completed | Chronotype and Premature Ejaculation | June 1, 2019 | December 30, 2019 | |
NCT04850703 | Completed | Phase 1/Phase 2 | Brain Networks Implicated in Lifelong Premature Ejaculation Patients | February 2, 2021 | February 4, 2023 |
NCT05462171 | Completed | The Prevalence of Erectile Dysfunction (ED) and Premature Ejaculation (PE) in Poland | July 1, 2022 | December 1, 2022 | |
NCT05517694 | Completed | N/A | Effect of Respiratory Exercises On The Intravaginal Ejaculation Latency Time | January 10, 2022 | January 15, 2023 |
NCT05964608 | Completed | N/A | The Effect of Behavioral Therapy Given to Men and Their Partners' | June 30, 2021 | March 15, 2022 |
NCT00537459 | Completed | Phase 2 | A Study On Concentrations Of 16448 In Blood And The Safety Of This Compound In Healthy Males With Premature Ejaculation | December 2006 | |
NCT00549211 | Completed | Phase 1 | A First Time in Human Study in Healthy Male Volunteers for Compound GSK557296. | October 2007 | |
NCT05556083 | Not yet recruiting | Phase 2 | Sildenafil Added Effect in Dapoxetine Non-responding Mono-symptomatic Premature Ejaculation (PE) | October 1, 2022 | November 1, 2023 |
NCT05052879 | Not yet recruiting | Phase 3 | Efficacy and Safety of Toronto Association in the Treatment of Erectile Dysfunction and Premature Ejaculation | July 2024 | August 2026 |
NCT06425211 | Recruiting | N/A | Effectiveness of Pelvic Floor Therapy for the Management of Erectile Dysfunction and Premature Ejaculation. | October 30, 2021 | December 2024 |
NCT06425224 | Recruiting | Phase 3 | Effectiveness and Safety of TENS Therapy for Premature Ejaculation | June 15, 2022 | June 2025 |
NCT04207723 | Recruiting | N/A | Transcutaneous Posterior Tibial Nerve Stimulation for Premature Ejaculation | July 15, 2020 | December 2024 |
NCT06172855 | Recruiting | N/A | The Study on the Effectiveness and Safety of Electroacupuncture at ST36 in Treating Primary Premature Ejaculation | January 1, 2024 | December 30, 2025 |
NCT00449709 | Terminated | Phase 1 | A Study To Assess The Pharmacokinetics Of Different Modified Release Formulations Of GSK221149 In Healthy Adult Subjects | March 2007 | |
NCT00983151 | Terminated | Phase 3 | Study to Evaluate Efficacy and Safety in Males Subjects With Premature Ejaculation | August 2009 | September 2010 |
NCT02378779 | Terminated | N/A | Consultations Reason for Genital, Urinary or Psychological Humans in General Practice | April 22, 2016 | April 22, 2018 |
NCT01917006 | Terminated | Phase 2 | A Safety and Efficacy Study of OnabotulinumtoxinA in Premature Ejaculation | August 7, 2013 | August 15, 2017 |
NCT00983736 | Terminated | Phase 3 | Study to Evaluate Efficacy and Safety in Male Subjects With Premature Ejaculation | October 2009 | September 2010 |
NCT03629769 | Unknown status | Phase 3 | Effects of Proxelan Somministration in Patients With Chronic Prostatitis | February 16, 2017 | September 30, 2018 |
NCT01798667 | Unknown status | Phase 2 | Clinical Trial to Evaluate the Efficacy and Safety of DA-8031 in Male Patients With Premature Ejaculation | January 2013 | September 2013 |
NCT01901029 | Unknown status | Male Reproductive Health of Floating Population: a Large-Scale Survey in Dongguan | July 2013 | September 2013 | |
NCT02028013 | Unknown status | Management of Sexual Dysfunction With Bioresonance Technique | January 2013 | August 2016 | |
NCT02109302 | Unknown status | N/A | Primary Premature Ejaculation Genetics | ||
NCT03879746 | Unknown status | Phase 3 | Effect of Tamsulosin on PE Compared With Paroxetine Hydrochloride | April 2019 | May 2020 |
NCT02241460 | Unknown status | Phase 3 | Efficacy of Promescent Lidocaine Spray in Men With Premature Ejaculation | March 2014 | December 2015 |
NCT02571101 | Unknown status | Phase 2 | A Phase 2 Study of On-demand Therapy With Clomipramine and Sildenafil Combination in Premature Ejaculation | November 2015 | June 2016 |
NCT02581826 | Unknown status | Phase 2 | Safety and Efficacy of Silodosin in the Treatment of Premature Ejaculation | October 2013 | December 2016 |
NCT04235192 | Unknown status | A Multicenter Case-control Study of Risk Factors for Premature Ejaculation in China's Shaanxi Province | July 31, 2019 | October 1, 2020 | |
NCT04361305 | Unknown status | Phase 3 | Observational Study of Pharmacological Treatment for Premature Ejaculation Concurrent With Erectile Dysfunction | June 3, 2020 | April 1, 2021 |
NCT03018743 | Unknown status | Discontinuation of Dapoxetine Treatment in Patients With Premature Ejaculation | January 2017 | January 2020 | |
NCT04703127 | Unknown status | Phase 3 | Effectiveness and Tolerability of the On-demand Use of Combined Dapoxetine With Tadalafil and Combined Dapoxetine With Lidocaine 5% Spray in Treatment of Patients With Lifelong Premature Ejaculation and Non-responding to Dapoxetine Alone. | March 30, 2020 | January 30, 2021 |
NCT00656552 | Unknown status | Early Phase 1 | Safety and Efficacy of Escitalopram in the Treatment of Premature Ejaculation | May 2008 | |
NCT05749614 | Unknown status | N/A | Precise Use of Lidocaine Cream to Treat Primary Premature Ejaculation | March 1, 2022 | April 1, 2023 |
NCT03177226 | Unknown status | N/A | Safety & Feasibility of Functional Electrical Stimulation for The Treatment of Premature Ejaculation | January 2017 | December 2017 |
NCT03177746 | Unknown status | Phase 4 | The Safety of Dapoxetine/Tadalafil Combination Therapy | December 31, 2022 | October 14, 2023 |
NCT04941690 | Unknown status | Erectile Dysfunction, Psychological Disorders, and Sexual Performance Among Men Seeking Medical Help for Fertility | June 26, 2021 | March 2022 | |
NCT05183334 | Unknown status | Phase 4 | Combined On-demand Sildenafil Citrate and Tramadol Hydrochloride for Treatment of Premature Ejaculation | December 30, 2021 | December 25, 2022 |
NCT03583112 | Unknown status | N/A | Investigation of the Changes of Brain Structure and Function in Premature Ejaculation Patients and the Effects of Dapoxetine on Central Neural Activity in Premature Ejaculation Patients | July 10, 2018 | December 2018 |
- Disase is a (Disease Ontology)
- DOID:10132
- Cross Reference ID (Disease Ontology)
- ICD10CM:F52.4
- Cross Reference ID (Disease Ontology)
- ICD9CM:302.75
- Cross Reference ID (Disease Ontology)
- MESH:D061686
- Cross Reference ID (Disease Ontology)
- NCI:C94349
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:123302009
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0033038
- HPO Human Phenotype ID (Human Phenotype Ontology)
- HP:0012876
- ICD10 preferred id (Insert disease from ICD10)
- D0004625
- ICD10 class code (Insert disease from ICD10)
- F52.4
- MeSH unique ID (MeSH (Medical Subject Headings))
- D061686